Ultragenyx to Participate at Investor Conferences in March Feb 23, 2026 04:30PM
TD Cowen Reiterates Buy Rating on Ultragenyx Pharma (RARE) Dec 29, 2025 01:50PM
Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $400 Million to OMERS Life Sciences Nov 4, 2025 04:01PM
TD Cowen: 'Ultragenyx Pharma (RARE) a Buying Oppy Ahead Of Dec '25 Readout' Jul 10, 2025 10:52AM
TD Cowen's Best Smidcap Ideas 2025 Jun 23, 2025 10:33AM
View Older Stories

Feb 24, 2025 04:30PM Ultragenyx to Participate at Investor Conferences in March
Oct 1, 2024 07:51AM TD Cowen Reiterates Buy Rating on Ultragenyx Pharma (RARE)
Jun 17, 2024 02:17PM TD Cowen Reiterates Buy Rating on Ultragenyx Pharma (RARE)
Jun 13, 2024 08:49PM Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Jun 12, 2024 04:05PM Ultragenyx Pharma (RARE) Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Jun 12, 2024 04:05PM Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Apr 24, 2024 09:42AM Ultragenyx Pharma (RARE) PT Raised to $61 at TD Cowen
Feb 27, 2024 04:30PM Ultragenyx to Participate at Investor Conferences in March
Oct 23, 2023 04:01PM Ultragenyx Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 19, 2023 05:49AM Ultragenyx Pharma (RARE) Prices 8.33M Share and Warrant Offering at $30/sh
Oct 18, 2023 09:16PM Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Oct 17, 2023 04:03PM Ultragenyx Pharma (RARE) Announces Proposed $300M Share Offering
Oct 17, 2023 04:02PM Ultragenyx Announces Proposed Public Offering of Common Stock
Feb 28, 2023 04:01PM Ultragenyx to Participate in Orphan Neuro Panel at Cowen Healthcare Conference
Feb 28, 2023 04:01PM Ultragenyx to Participate in Orphan Neuro Panel at Cowen Healthcare Conference
Jul 14, 2022 08:34AM Ultragenyx Pharma (RARE) Sells Portion of Future North American Royalties on Crysvita for $500M to OMERS
Jul 14, 2022 08:30AM Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $500 Million to OMERS Capital Markets
Jul 14, 2022 08:30AM Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $500 Million to OMERS Capital Markets
Mar 2, 2022 04:01PM Ultragenyx to Participate in the Cowen Health Care Conference
Mar 2, 2022 04:01PM Ultragenyx to Participate in the Cowen Health Care Conference
Jan 10, 2022 01:42PM Ultragenyx Pharma (RARE) PT Lowered to $124 at Cowen, Following Earnings
Feb 17, 2021 04:01PM Ultragenyx to Present at Upcoming Investor Conferences
Feb 17, 2021 04:01PM Ultragenyx to Present at Upcoming Investor Conferences
Nov 2, 2020 11:20AM Ultragenyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Nov 2, 2020 11:20AM Ultragenyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 29, 2020 05:54AM Ultragenyx Pharma (RARE) Prices 4.44M Share Common Offering at $90/Sh
Oct 28, 2020 07:00PM Ultragenyx Announces Pricing of Public Offering of Common Stock
Oct 28, 2020 07:00PM Ultragenyx Announces Pricing of Public Offering of Common Stock
Oct 28, 2020 07:47AM Ultragenyx Pharma (RARE) Announces Proposed $400M Public Offering of Common Stock
Oct 28, 2020 07:47AM Ultragenyx Announces Proposed Public Offering of Common Stock
Oct 28, 2020 07:47AM Ultragenyx Announces Proposed Public Offering of Common Stock
Oct 28, 2020 06:59AM Ultragenyx Pharma (RARE) PT Raised to $116 at Cowen
Jan 24, 2020 06:37AM Ultragenyx Pharma (RARE) PT Raised to $75 at Cowen
May 7, 2019 07:53AM Ultragenyx Pharma (RARE) PT Raised to $79 at Cowen on Strong Crysvita Sales
Mar 11, 2019 08:30AM Ultragenyx to Present at Upcoming Investor Conferences
Mar 11, 2019 04:30AM Ultragenyx to Present at Upcoming Investor Conferences
Feb 27, 2019 05:49AM Ultragenyx Pharma (RARE) Prices 5.07M Share Common Offering at $60/Sh
Feb 26, 2019 07:13PM Ultragenyx Announces Pricing of Public Offering of Common Stock
Feb 26, 2019 07:13PM Ultragenyx Announces Pricing of Public Offering of Common Stock
Feb 25, 2019 04:07PM Cowen Starts Ultragenyx Pharma (RARE) at Outperform
Feb 25, 2019 04:02PM Ultragenyx Pharma (RARE) to Offer Up to $250M in CommonStock
Feb 25, 2019 04:01PM Ultragenyx Announces Proposed Public Offering of Common Stock
Feb 25, 2019 04:01PM Ultragenyx Announces Proposed Public Offering of Common Stock
Mar 8, 2018 08:00AM Ultragenyx to Present at Upcoming Investor Conferences
Mar 8, 2018 08:00AM Ultragenyx to Present at Upcoming Investor Conferences
Jan 24, 2018 05:49AM Ultragenyx Pharma (RARE) Prices 4.386M Share Common Offering at $57/Sh
Jan 23, 2018 09:40PM Ultragenyx Announces Pricing of Public Offering of Common Stock
Jan 23, 2018 09:40PM Ultragenyx Announces Pricing of Public Offering of Common Stock
Jan 22, 2018 04:16PM Ultragenyx Pharma (RARE) Plans $175M Public Offering of Common Stock
Jan 22, 2018 04:15PM Ultragenyx Announces Proposed Public Offering of Common Stock
View Older Stories